| 000 | 01352 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250512201149.0 | ||
| 264 | 0 | _c19820109 | |
| 008 | 198201s 0 0 eng d | ||
| 022 | _a0078-5334 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMcAuslan, B R | |
| 245 | 0 | 0 |
_aCellular and molecular mechanisms in angiogenesis. _h[electronic resource] |
| 260 |
_bTransactions of the ophthalmological societies of the United Kingdom _cSep 1980 |
||
| 300 |
_a354-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnterior Chamber _xblood supply |
| 650 | 0 | 4 |
_aAspirin _xpharmacology |
| 650 | 0 | 4 | _aCarcinoma 256, Walker |
| 650 | 0 | 4 |
_aCell Movement _xdrug effects |
| 650 | 0 | 4 |
_aCopper _xpharmacology |
| 650 | 0 | 4 | _aCopper Sulfate |
| 650 | 0 | 4 |
_aCornea _xblood supply |
| 650 | 0 | 4 |
_aEndothelium _xcytology |
| 650 | 0 | 4 |
_aGrowth Substances _xpharmacology |
| 650 | 0 | 4 |
_aLeukocytes _xphysiology |
| 650 | 0 | 4 |
_aNeovascularization, Pathologic _xdrug effects |
| 650 | 0 | 4 |
_aProstaglandins E _xpharmacology |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aSulfates _xpharmacology |
| 650 | 0 | 4 |
_aTissue Extracts _xpharmacology |
| 700 | 1 | _aGole, G A | |
| 773 | 0 |
_tTransactions of the ophthalmological societies of the United Kingdom _gvol. 100 _gno. 3 _gp. 354-8 |
|
| 999 |
_c6171116 _d6171116 |
||